Vimarsana
Biggest News Aggregation in the World

Floor Mobility News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Floor Mobility. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Floor Mobility Today - Breaking & Trending Today

Sio Gene Therapies reports positive interim data for gene therapy trial - Vimarsana News

Sio Gene Therapies reports positive interim data for gene therapy trial

Sio Gene Therapies, a clinical-stage company focused on developing gene therapies for neurodegenerative diseases, presented positive interim data from its Phase I/II study of AXO-AAV-GM1, an adeno-associated viral vector-based gene therapy candidate for GM1 gangliosidosis that was licensed from UMass Chan.

Sio Gene Therapies Announces Positive Interim Safety and Biomarker Data from Ongoing Phase 1/2 ... - Vimarsana News

Sio Gene Therapies Announces Positive Interim Safety and Biomarker Data from Ongoing Phase 1/2 ...

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Source: apnews.com
Sio Gene Therapies Announces Positive Six-Month Follow-Up Data from Low-Dose Cohort of Phase ... - Vimarsana News

Sio Gene Therapies Announces Positive Six-Month Follow-Up Data from Low-Dose Cohort of Phase ...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Sio Gene Therapies Announces Positive Six-Month Follow-Up Data from Low-Dose Cohort of Phase ... Sio Gene TherapiesDecember 15, 2020 GMT -  Generally well-tolerated with a favorable safety profile in five patients -  Serum beta-galactosidase enzyme activity increased in all patients at all timepoints between Day 7 and Month 6, representing an approximate doubling in enzyme activity after gene transfer -  At Month 6, enzyme activity restored to 23-57% (mean: 38%) of normal reference levels -  ...

Source: apnews.com